Literature DB >> 27290721

Partially-covered stent placement versus surgical gastrojejunostomy for the palliation of malignant gastroduodenal obstruction secondary to pancreatic cancer.

Jiaywei Tsauo1, Moon-Won Yoo2, Ho-Young Song3, Dae Wook Hwang2, Jung-Hoon Park1, Min-Hee Ryu4, Song Cheol Kim2, Jeong Hoon Lee5, Kee Don Choi5, Jin Hyoung Kim1, Do Hoon Kim5.   

Abstract

PURPOSE: To compare the outcomes of partially covered self-expandable metallic stent (SEMS) placement with surgical gastrojejunostomy (GJ) in patients with gastroduodenal obstruction caused by pancreatic cancer.
METHODS: The medical records of 107 patients with gastroduodenal obstruction caused by pancreatic cancer who underwent fluoroscopic partially covered SEMS placement (n = 75) or surgical GJ (n = 32) at our institution were reviewed.
RESULTS: The technical (100% vs. 100%; P > 0.999) and clinical (98.7% vs. 96.9%; P = 0.511) success rates were similar between the SEMS and GJ group. The mean gastric outlet obstruction scoring system score was higher in the SEMS group at 1 week after treatment (2.3 ± 0.5 vs. 1.2 ± 0.4; P < 0.001) but was similar between the two groups at 1 month (2.7 ± 0.5 vs. 2.8 ± 0.5; P = 0.242). The median hospital stay was shorter in the SEMS group than in the GJ group (7 vs. 14 days; P < 0.001). The overall complication (22.7% vs. 28.1%; P = 0.547) and reintervention (21.3% vs. 25.0%; P = 0.677) rates were similar between the two groups. The median patency (99 vs. 138 days; P = 0.102) and survival (106 vs. 140 days; P = 0.245) were also similar between the two groups.
CONCLUSION: The outcomes of partially covered SEMS placement seem to be more favorable than surgical GJ in patients with gastroduodenal obstruction caused by pancreatic cancer.

Entities:  

Keywords:  Gastric outlet obstruction; Pancreatic neoplasms; Prostheses and implants; Pyloric stenosis

Mesh:

Year:  2016        PMID: 27290721     DOI: 10.1007/s00261-016-0810-z

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

Review 1.  Palliative therapy in pancreatic cancer-interventional treatment with stents.

Authors:  Alexander Waldthaler; Wiktor Rutkowski; Roberto Valente; Urban Arnelo; J-Matthias Löhr
Journal:  Transl Gastroenterol Hepatol       Date:  2019-01-31

2.  Palliative surgical bypass is superior to palliative endoscopic stenting in patients with malignant gastric outlet obstruction: systematic review and meta-analysis.

Authors:  Ioannis Mintziras; Michael Miligkos; Sabine Wächter; Jerena Manoharan; Detlef Klaus Bartsch
Journal:  Surg Endosc       Date:  2019-07-22       Impact factor: 4.584

Review 3.  Efficacy and safety of endoscopic duodenal stent versus endoscopic or surgical gastrojejunostomy to treat malignant gastric outlet obstruction: systematic review and meta-analysis.

Authors:  Rajesh Krishnamoorthi; Shivanand Bomman; Petros Benias; Richard A Kozarek; Joyce A Peetermans; Edmund McMullen; Ornela Gjata; Shayan S Irani
Journal:  Endosc Int Open       Date:  2022-06-10

Review 4.  Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction.

Authors:  Emma Upchurch; Mark Ragusa; Roberto Cirocchi
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30

5.  The Palliative Effect of Endoscopic Uncovered Self-expandable Metallic Stent Placement Versus Gastrojejunostomy on Malignant Gastric Outlet Obstruction: A Pilot Study with a Retrospective Chart Review in Saga, Japan.

Authors:  Takahiro Yukimoto; Tomohito Morisaki; Sho Komukai; Hisako Yoshida; Daisuke Yamaguchi; Nanae Tsuruoka; Koichi Miyahara; Yasuhisa Sakata; Shinichi Shibasaki; Seiji Tsunada; Takahiro Noda; Seiji Yunotani; Kazuma Fujimoto
Journal:  Intern Med       Date:  2018-02-09       Impact factor: 1.271

6.  Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction.

Authors:  Kentaro Yamao; Masayuki Kitano; Yasutaka Chiba; Takeshi Ogura; Takaaki Eguchi; Ichiro Moriyama; Yukitaka Yamashita; Hironari Kato; Takahisa Kayahara; Noriyuki Hoki; Yoshinobu Okabe; Hideyuki Shiomi; Yoshitaka Nakai; Yoshinori Kushiyama; Yoshifumi Fujimoto; Shiro Hayashi; Shigeki Bamba; Yasushi Kudo; Nobuaki Azemoto; Toshiharu Ueki; Norimitsu Uza; Masanori Asada; Kazuya Matsumoto; Hiroko Nebiki; Hiroshi Takihara; Chisio Noguchi; Hideki Kamada; Kojiro Nakase; Daisuke Goto; Tsuyoshi Sanuki; Tetsuya Koga; Shinichi Hashimoto; Hidefumi Nishikiori; Masahiro Serikawa; Keiji Hanada; Ken Hirao; Masaya Ohana; Imakiire Kazuyuki; Takao Kato; Motoyuki Yoshida; Hirofumi Kawamoto
Journal:  Gut       Date:  2020-11-22       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.